Transplant diagnostics are critical tests conducted both before and after organ transplantation to assess and manage a patient's medical conditions. These diagnostics help prevent complications, such as healthcare-associated infections (HAIs), which can be life-threatening for immunocompromised individuals. This field represents a collaborative effort between healthcare professionals and laboratory experts, leading to improved patient outcomes.

Organ transplantation involves transferring organs, such as the liver, pancreas, lungs, kidneys, and heart, to address organ failure. Human leukocyte antigens (HLAs) on cell surfaces play a key role in body recognition and the rejection of transplanted tissues.

Advancements in technologies and screening methods, such as genetic profiling and cross-matching, are making transplants a viable option for restoring health and prolonging life. The rising number of transplant procedures in major countries contributes to the increasing compound annual growth rate (CAGR) of the transplant market. Additionally, the growing prevalence of chronic diseases leading to organ failure is driving demand for transplant therapies. Specialized transplant diagnostic procedures, including histocompatibility testing, blood profiling, and genomic profiling, utilize advanced molecular diagnostic platforms that integrate cutting-edge technologies with traditional PCR and NGS equipment, resulting in high costs for these advanced tools.